389 Chemotherapy during pregnancy and neonatal outcome: a retrospective analysis on 47 patients

Eugenia DI Loreto, Alessandra Familiari, Veronica Accurti, Tiziana Boggini, Carlotta Castellani, Gianpiero Polverino, Julia Bewart, Monica Fumagalli, Fedro Alessandro Peccatori, Giovanna Scarfone
2020 Fertility pregnancy   unpublished
disease, 2 (2%) were alive with disease, and 3 patients (3%) died from BOT. Conclusions Despite the recurrence high rate, the survivals and pregnancy outcomes indicate that FSS could be considered in advanced BOTs. Among predictors of recurrence, oophorectomy (vs. cystectomy) has resulted not significant as in earlystage BOTs likely due to the advanced-stage setting. Size of extra-ovarian lesions and presence of invasive implants were the only significant predictors. Completeness of
more » ... ness of cytoreduction was lacking significance likely because of low number of patients with residual disease. Disclosures All authors declare no financial support or relationships that may pose conflict of interest. Abstract 389 Table 2 Results of the linear regression analysis of factors associated with neonatal outcomes BW=Birthweight; Hb=Haemoglobin, WBC=White Blood Cells
doi:10.1136/ijgc-2020-esgo.85 fatcat:b7jn7i5uzjdmpdp2iqu3ugfywq